Topics

Pharmaceutical Industry

Angry lawmakers grill CEO over EpiPen price hikes

Angry lawmakers grill CEO over EpiPen price hikes

Lawmakers chastised Mylan's chief executive for amassing an $18 million salary at a contentious congressional hearing Wednesday afternoon, as she evaded questions about how much profit the pharmaceutical company made off the lifesaving allergy drug EpiPen.

Jason Chaffetz, R-Utah, chairman of the House Committee on Oversight and Government Reform, held up an EpiPen to punctuate his point that epinephrine - "the juice" inside the device - costs about $1. The list price for a two-pack of the pens is $608, up about 500 percent in a decade.

The hearing was the latest drug-pricing outrage to unite politicians from both sides of the aisle. It came months after...

73°